Behan, Aine and Hryniewiecka, Magdalena and O'Tuathaigh, Colm MP and Kinsella, Anthony and Cannon, Mary and Karayiorgou, Maria and Gagos, Joseph A and Waddington, John L and Cotter, David R (2012) Chronic adolescent exposure to Delta-9-Tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways. Neuropsychopharmacology, 37, pp. 1773-1783. 10.1038/npp.2012.24.

Dawes, Christopher and McGreal, Samuel Joy and Marwaha, Shivika and Prados, Jose and Reheis, Antoine and Dumitrescu, Alin and Waddington, John L and Moran, Paula M and O'Tuathaigh, Colm (2024) Overshadowing and salience attribution in relation to cannabis use. Schizophrenia research. Cognition, 37, 100315. https://doi.org/10.1016/j.scog.2024.100315.

Hill, Michele and Crumlish, Niall and Whitty, Petter and Clarke, Mary and Browne, Stephen and Kamali, Moayyad and Kinsella, Anthony and Waddington, John L and Larkin, Conall and O'Callaghan, Eadbhard (2010) Nonadherence to medication four years after a first episode of psychosis and associated risk factors. Psychiatric Services, 61, (2), pp. 189-92. https://doi.org/10.1176/ps.2010.61.2.189.

Madigan, Kevin and Brennan, Daria and Lawlor, Elizabeth and Turner, Niall and Kinsella, Anthony and O'Connor, John J and Russel, Vincent and Waddington, John L and O'Callaghan, Eadbhard (2013) A multi-center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research, 143, pp. 138-142. doi: 10.1016/j.schres.2012.10.018.

O'Tuathaigh, Colm M P and Dawes, Christopher and Bickerdike, Andrea and Duggan, Eileen and O'Neill, Cian and Waddington, John L and Moran, Paula M (2020) Does cannabis use predict psychometric schizotypy via aberrant salience? Schizophrenia Research, 220, pp. 194-200. https://doi.org/10.1016/j.schres.2020.03.021.

O'Tuathaigh, Colm MP and Gantois, Ilse and Waddington, John L (2014) Genetic dissection of the psychotomimetic effects of cannabinoid exposure. Progress in Neuro-psychopharmacology & Biological Psychiatry, 52, pp. 33-40. doi: 10.1016/j.pnpbp.2013.11.002.